ASND Stock Summary and Trading Ideas (Ascendis Pharma A/S - American Depositary Shares | NASDAQ:ASND)

Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

Ascendis Pharma A/S - American Depositary Shares trades on the NASDAQ stock market under the symbol ASND.

As of December 3, 2024, ASND stock price declined to $132.27 with 104,743 million shares trading.

ASND has a beta of 0.92, meaning it tends to be less sensitive to market movements. ASND has a correlation of 0.07 to the broad based SPY ETF.

ASND has a market cap of $7.90 billion. This is considered a Mid Cap stock.

Last quarter Ascendis Pharma A/S - American Depositary Shares reported $64 million in Revenue and -$1.89 earnings per share. This fell short of revenue expectation by $-7 million and missed earnings estimates by -$.37.

In the last 3 years, ASND traded as high as $161.00 and as low as $61.58.

The top ETF exchange traded funds that ASND belongs to (by Net Assets): IBB, SPDW, FDG, MEDI, TCAF.

ASND has underperformed the market in the last year with a return of +27.1%, while the SPY ETF gained +32.8%. In the last 3 month period, ASND fell short of the market, returning -4.5%, while SPY returned +7.2%. However, in the most recent 2 weeks ASND has outperformed the stock market by returning +8.4%, while SPY returned +2.5%.

ASND support price is $130.09 and resistance is $136.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASND shares will trade within this expected range on the day.